Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease

Dement Geriatr Cogn Disord. 2013;36(3-4):163-70. doi: 10.1159/000350872. Epub 2013 Jul 23.

Abstract

The relationship between the apolipoprotein E (ApoE) ε4 genotype and an increased risk of developing Alzheimer's disease (AD) has been well established in Caucasians but is less established among other ethnicities. ApoE ε4 has also been associated with several other neurological disorders. Whether ApoΕ4 ε4 is a risk factor for frontotemporal dementia (FTD) remains controversial. This study examined 432 patients with AD, 62 with FTD, and 381 sex- and age-matched controls. The ApoE ε4 allele frequency was significantly increased among patients in the AD and FTD groups compared with controls. The frequency of the ApoΕ ε4 allele was 24.86% in late-onset AD (p < 0.01), 18.02% in early-onset AD (p < 0.01), 16.13% in FTD (p < 0.01), and 7.34% in controls. ApoΕ ε4 prevalence was similar in the FTD and AD groups. The present study suggests that the ApoE ε4 allele is a risk factor for both disorders.

MeSH terms

  • Aged
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / psychology
  • Aniline Compounds
  • Apolipoprotein E4 / genetics*
  • Asian People
  • China / epidemiology
  • Diagnostic and Statistical Manual of Mental Disorders
  • Female
  • Fluorodeoxyglucose F18
  • Frontotemporal Dementia / genetics*
  • Frontotemporal Dementia / psychology
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Risk Factors
  • Thiazoles
  • Tomography, X-Ray Computed

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Aniline Compounds
  • Apolipoprotein E4
  • Radiopharmaceuticals
  • Thiazoles
  • Fluorodeoxyglucose F18